Skip to main content
FinSpry Logo
FinSpry
HAE logo
HAE
(NYSE)
Haemonetics Corporation
$56.83-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Haemonetics (HAE) Stock Price & Financial Analysis

Haemonetics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$55.30 - $57.33
52-Week High$87.32
52-Week Low$47.32
Open$56.41
Volume426.37K
Average Volume (3M)426.37K
Market Cap2.67B
Shares Outstanding46.99M
P/E Ratio (TTM)15.06
Forward P/E11.17
Price to Sales (P/S)2.00
Price to Book (P/B)2.90
EV/EBITDA9.63
Revenue (TTM)1.32B
Net Income (TTM)175.44M
Free Cash Flow (TTM)308.07M
EPS (TTM)$3.73
Profit Margin13.31%
Operating Margin18.19%
Return on Equity (ROE)19.25%
Debt to Equity1.34
50-Day MA$61.63
200-Day MA$65.06
52-Week Change-10.76%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Haemonetics

What is the current stock price for HAE?

As of the latest trading session, HAE stock trades at $56.83. The 52-week range is $47.32–$87.32, with a day range of $55.30–$57.33.

What is the P/E ratio for HAE?

Haemonetics's trailing P/E ratio is 15.1, meaning investors pay $15.1 for every $1 of annual earnings. The forward P/E is 11.2, reflecting analyst expectations for future earnings. Haemonetics operates in the Healthcare sector.

Does HAE pay dividends?

Haemonetics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for HAE?

Based on 4 analysts, the consensus for HAE is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of HAE?

Haemonetics's market capitalization is $2.67B, classifying it as a mid-cap company. Haemonetics operates in the Healthcare sector within the Medical Devices industry.